img

Global Rifampicin Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rifampicin Market Insights, Forecast to 2034

Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire's disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
Global Rifampicin market is expected to reach to US$ 133 million in 2024, with a positive growth of %, compared with US$ 124 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rifampicin industry is evaluated to reach US$ 193 million in 2029. The CAGR will be 6.4% during 2024 to 2029.
Globally, Rifampicin key manufacturers include Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES, Hebei Xingang Pharmaceutical, Mercator Pharmaceutical Solutions and ASIAN PHARMACY, etc. Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Rifampicin were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Rifampicin market and estimated to attract more attentions from industry insiders and investors.
Rifampicin can be divided into Oral and Intravenous Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Rifampicin is widely used in various fields, such as Tuberculosis, Leprosy, Legionnaire's Disease and Others, etc. Tuberculosis provides greatest supports to the Rifampicin industry development. In 2022, global % sales of Rifampicin went into Tuberculosis filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Rifampicin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rifampicin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
Segment by Type
Oral
Intravenous Injection

Segment by Application


Tuberculosis
Leprosy
Legionnaire's Disease
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rifampicin plant distribution, commercial date of Rifampicin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rifampicin introduction, etc. Rifampicin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Rifampicin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rifampicin Product Introduction
1.2 Market by Type
1.2.1 Global Rifampicin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Intravenous Injection
1.3 Market by Application
1.3.1 Global Rifampicin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Tuberculosis
1.3.3 Leprosy
1.3.4 Legionnaire's Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rifampicin Sales Estimates and Forecasts 2018-2029
2.2 Global Rifampicin Revenue by Region
2.2.1 Global Rifampicin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rifampicin Revenue by Region (2018-2024)
2.2.3 Global Rifampicin Revenue by Region (2024-2029)
2.2.4 Global Rifampicin Revenue Market Share by Region (2018-2029)
2.3 Global Rifampicin Sales Estimates and Forecasts 2018-2029
2.4 Global Rifampicin Sales by Region
2.4.1 Global Rifampicin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rifampicin Sales by Region (2018-2024)
2.4.3 Global Rifampicin Sales by Region (2024-2029)
2.4.4 Global Rifampicin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rifampicin Sales by Manufacturers
3.1.1 Global Rifampicin Sales by Manufacturers (2018-2024)
3.1.2 Global Rifampicin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rifampicin in 2022
3.2 Global Rifampicin Revenue by Manufacturers
3.2.1 Global Rifampicin Revenue by Manufacturers (2018-2024)
3.2.2 Global Rifampicin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rifampicin Revenue in 2022
3.3 Global Key Players of Rifampicin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rifampicin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rifampicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rifampicin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rifampicin, Product Offered and Application
3.8 Global Key Manufacturers of Rifampicin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rifampicin Sales by Type
4.1.1 Global Rifampicin Historical Sales by Type (2018-2024)
4.1.2 Global Rifampicin Forecasted Sales by Type (2024-2029)
4.1.3 Global Rifampicin Sales Market Share by Type (2018-2029)
4.2 Global Rifampicin Revenue by Type
4.2.1 Global Rifampicin Historical Revenue by Type (2018-2024)
4.2.2 Global Rifampicin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rifampicin Revenue Market Share by Type (2018-2029)
4.3 Global Rifampicin Price by Type
4.3.1 Global Rifampicin Price by Type (2018-2024)
4.3.2 Global Rifampicin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rifampicin Sales by Application
5.1.1 Global Rifampicin Historical Sales by Application (2018-2024)
5.1.2 Global Rifampicin Forecasted Sales by Application (2024-2029)
5.1.3 Global Rifampicin Sales Market Share by Application (2018-2029)
5.2 Global Rifampicin Revenue by Application
5.2.1 Global Rifampicin Historical Revenue by Application (2018-2024)
5.2.2 Global Rifampicin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rifampicin Revenue Market Share by Application (2018-2029)
5.3 Global Rifampicin Price by Application
5.3.1 Global Rifampicin Price by Application (2018-2024)
5.3.2 Global Rifampicin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rifampicin Market Size by Type
6.1.1 US & Canada Rifampicin Sales by Type (2018-2029)
6.1.2 US & Canada Rifampicin Revenue by Type (2018-2029)
6.2 US & Canada Rifampicin Market Size by Application
6.2.1 US & Canada Rifampicin Sales by Application (2018-2029)
6.2.2 US & Canada Rifampicin Revenue by Application (2018-2029)
6.3 US & Canada Rifampicin Market Size by Country
6.3.1 US & Canada Rifampicin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rifampicin Sales by Country (2018-2029)
6.3.3 US & Canada Rifampicin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rifampicin Market Size by Type
7.1.1 Europe Rifampicin Sales by Type (2018-2029)
7.1.2 Europe Rifampicin Revenue by Type (2018-2029)
7.2 Europe Rifampicin Market Size by Application
7.2.1 Europe Rifampicin Sales by Application (2018-2029)
7.2.2 Europe Rifampicin Revenue by Application (2018-2029)
7.3 Europe Rifampicin Market Size by Country
7.3.1 Europe Rifampicin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rifampicin Sales by Country (2018-2029)
7.3.3 Europe Rifampicin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rifampicin Market Size
8.1.1 China Rifampicin Sales (2018-2029)
8.1.2 China Rifampicin Revenue (2018-2029)
8.2 China Rifampicin Market Size by Application
8.2.1 China Rifampicin Sales by Application (2018-2029)
8.2.2 China Rifampicin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rifampicin Market Size by Type
9.1.1 Asia Rifampicin Sales by Type (2018-2029)
9.1.2 Asia Rifampicin Revenue by Type (2018-2029)
9.2 Asia Rifampicin Market Size by Application
9.2.1 Asia Rifampicin Sales by Application (2018-2029)
9.2.2 Asia Rifampicin Revenue by Application (2018-2029)
9.3 Asia Rifampicin Sales by Region
9.3.1 Asia Rifampicin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rifampicin Revenue by Region (2018-2029)
9.3.3 Asia Rifampicin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rifampicin Market Size by Type
10.1.1 Middle East, Africa and Latin America Rifampicin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rifampicin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rifampicin Market Size by Application
10.2.1 Middle East, Africa and Latin America Rifampicin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rifampicin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rifampicin Sales by Country
10.3.1 Middle East, Africa and Latin America Rifampicin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rifampicin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rifampicin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Rifampicin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Wellona Pharma
11.2.1 Wellona Pharma Company Information
11.2.2 Wellona Pharma Overview
11.2.3 Wellona Pharma Rifampicin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Wellona Pharma Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Wellona Pharma Recent Developments
11.3 AVANSCURE LIFESCIENCES
11.3.1 AVANSCURE LIFESCIENCES Company Information
11.3.2 AVANSCURE LIFESCIENCES Overview
11.3.3 AVANSCURE LIFESCIENCES Rifampicin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 AVANSCURE LIFESCIENCES Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AVANSCURE LIFESCIENCES Recent Developments
11.4 Hebei Xingang Pharmaceutical
11.4.1 Hebei Xingang Pharmaceutical Company Information
11.4.2 Hebei Xingang Pharmaceutical Overview
11.4.3 Hebei Xingang Pharmaceutical Rifampicin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Hebei Xingang Pharmaceutical Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hebei Xingang Pharmaceutical Recent Developments
11.5 Mercator Pharmaceutical Solutions
11.5.1 Mercator Pharmaceutical Solutions Company Information
11.5.2 Mercator Pharmaceutical Solutions Overview
11.5.3 Mercator Pharmaceutical Solutions Rifampicin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mercator Pharmaceutical Solutions Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mercator Pharmaceutical Solutions Recent Developments
11.6 ASIAN PHARMACY
11.6.1 ASIAN PHARMACY Company Information
11.6.2 ASIAN PHARMACY Overview
11.6.3 ASIAN PHARMACY Rifampicin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 ASIAN PHARMACY Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ASIAN PHARMACY Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rifampicin Industry Chain Analysis
12.2 Rifampicin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rifampicin Production Mode & Process
12.4 Rifampicin Sales and Marketing
12.4.1 Rifampicin Sales Channels
12.4.2 Rifampicin Distributors
12.5 Rifampicin Customers
13 Market Dynamics
13.1 Rifampicin Industry Trends
13.2 Rifampicin Market Drivers
13.3 Rifampicin Market Challenges
13.4 Rifampicin Market Restraints
14 Key Findings in The Global Rifampicin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rifampicin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Intravenous Injection
Table 4. Global Rifampicin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rifampicin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Rifampicin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Rifampicin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Rifampicin Revenue Market Share by Region (2018-2024)
Table 9. Global Rifampicin Revenue Market Share by Region (2024-2029)
Table 10. Global Rifampicin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Rifampicin Sales by Region (2018-2024) & (MT)
Table 12. Global Rifampicin Sales by Region (2024-2029) & (MT)
Table 13. Global Rifampicin Sales Market Share by Region (2018-2024)
Table 14. Global Rifampicin Sales Market Share by Region (2024-2029)
Table 15. Global Rifampicin Sales by Manufacturers (2018-2024) & (MT)
Table 16. Global Rifampicin Sales Share by Manufacturers (2018-2024)
Table 17. Global Rifampicin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Rifampicin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Rifampicin, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Rifampicin Price by Manufacturers 2018-2024 (USD/MT)
Table 21. Global Rifampicin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rifampicin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifampicin as of 2022)
Table 23. Global Key Manufacturers of Rifampicin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rifampicin, Product Offered and Application
Table 25. Global Key Manufacturers of Rifampicin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rifampicin Sales by Type (2018-2024) & (MT)
Table 28. Global Rifampicin Sales by Type (2024-2029) & (MT)
Table 29. Global Rifampicin Sales Share by Type (2018-2024)
Table 30. Global Rifampicin Sales Share by Type (2024-2029)
Table 31. Global Rifampicin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Rifampicin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Rifampicin Revenue Share by Type (2018-2024)
Table 34. Global Rifampicin Revenue Share by Type (2024-2029)
Table 35. Rifampicin Price by Type (2018-2024) & (USD/MT)
Table 36. Global Rifampicin Price Forecast by Type (2024-2029) & (USD/MT)
Table 37. Global Rifampicin Sales by Application (2018-2024) & (MT)
Table 38. Global Rifampicin Sales by Application (2024-2029) & (MT)
Table 39. Global Rifampicin Sales Share by Application (2018-2024)
Table 40. Global Rifampicin Sales Share by Application (2024-2029)
Table 41. Global Rifampicin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Rifampicin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Rifampicin Revenue Share by Application (2018-2024)
Table 44. Global Rifampicin Revenue Share by Application (2024-2029)
Table 45. Rifampicin Price by Application (2018-2024) & (USD/MT)
Table 46. Global Rifampicin Price Forecast by Application (2024-2029) & (USD/MT)
Table 47. US & Canada Rifampicin Sales by Type (2018-2024) & (MT)
Table 48. US & Canada Rifampicin Sales by Type (2024-2029) & (MT)
Table 49. US & Canada Rifampicin Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Rifampicin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Rifampicin Sales by Application (2018-2024) & (MT)
Table 52. US & Canada Rifampicin Sales by Application (2024-2029) & (MT)
Table 53. US & Canada Rifampicin Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Rifampicin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Rifampicin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Rifampicin Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Rifampicin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Rifampicin Sales by Country (2018-2024) & (MT)
Table 59. US & Canada Rifampicin Sales by Country (2024-2029) & (MT)
Table 60. Europe Rifampicin Sales by Type (2018-2024) & (MT)
Table 61. Europe Rifampicin Sales by Type (2024-2029) & (MT)
Table 62. Europe Rifampicin Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Rifampicin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Rifampicin Sales by Application (2018-2024) & (MT)
Table 65. Europe Rifampicin Sales by Application (2024-2029) & (MT)
Table 66. Europe Rifampicin Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Rifampicin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Rifampicin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Rifampicin Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Rifampicin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Rifampicin Sales by Country (2018-2024) & (MT)
Table 72. Europe Rifampicin Sales by Country (2024-2029) & (MT)
Table 73. China Rifampicin Sales by Type (2018-2024) & (MT)
Table 74. China Rifampicin Sales by Type (2024-2029) & (MT)
Table 75. China Rifampicin Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Rifampicin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Rifampicin Sales by Application (2018-2024) & (MT)
Table 78. China Rifampicin Sales by Application (2024-2029) & (MT)
Table 79. China Rifampicin Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Rifampicin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Rifampicin Sales by Type (2018-2024) & (MT)
Table 82. Asia Rifampicin Sales by Type (2024-2029) & (MT)
Table 83. Asia Rifampicin Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Rifampicin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Rifampicin Sales by Application (2018-2024) & (MT)
Table 86. Asia Rifampicin Sales by Application (2024-2029) & (MT)
Table 87. Asia Rifampicin Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Rifampicin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Rifampicin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Rifampicin Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Rifampicin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Rifampicin Sales by Region (2018-2024) & (MT)
Table 93. Asia Rifampicin Sales by Region (2024-2029) & (MT)
Table 94. Middle East, Africa and Latin America Rifampicin Sales by Type (2018-2024) & (MT)
Table 95. Middle East, Africa and Latin America Rifampicin Sales by Type (2024-2029) & (MT)
Table 96. Middle East, Africa and Latin America Rifampicin Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rifampicin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rifampicin Sales by Application (2018-2024) & (MT)
Table 99. Middle East, Africa and Latin America Rifampicin Sales by Application (2024-2029) & (MT)
Table 100. Middle East, Africa and Latin America Rifampicin Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rifampicin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rifampicin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Rifampicin Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rifampicin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rifampicin Sales by Country (2018-2024) & (MT)
Table 106. Middle East, Africa and Latin America Rifampicin Sales by Country (2024-2029) & (MT)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Rifampicin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Sanofi Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. Wellona Pharma Company Information
Table 113. Wellona Pharma Description and Major Businesses
Table 114. Wellona Pharma Rifampicin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Wellona Pharma Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Wellona Pharma Recent Developments
Table 117. AVANSCURE LIFESCIENCES Company Information
Table 118. AVANSCURE LIFESCIENCES Description and Major Businesses
Table 119. AVANSCURE LIFESCIENCES Rifampicin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. AVANSCURE LIFESCIENCES Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. AVANSCURE LIFESCIENCES Recent Developments
Table 122. Hebei Xingang Pharmaceutical Company Information
Table 123. Hebei Xingang Pharmaceutical Description and Major Businesses
Table 124. Hebei Xingang Pharmaceutical Rifampicin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Hebei Xingang Pharmaceutical Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Hebei Xingang Pharmaceutical Recent Developments
Table 127. Mercator Pharmaceutical Solutions Company Information
Table 128. Mercator Pharmaceutical Solutions Description and Major Businesses
Table 129. Mercator Pharmaceutical Solutions Rifampicin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Mercator Pharmaceutical Solutions Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Mercator Pharmaceutical Solutions Recent Developments
Table 132. ASIAN PHARMACY Company Information
Table 133. ASIAN PHARMACY Description and Major Businesses
Table 134. ASIAN PHARMACY Rifampicin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. ASIAN PHARMACY Rifampicin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. ASIAN PHARMACY Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Rifampicin Distributors List
Table 140. Rifampicin Customers List
Table 141. Rifampicin Market Trends
Table 142. Rifampicin Market Drivers
Table 143. Rifampicin Market Challenges
Table 144. Rifampicin Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Rifampicin Product Picture
Figure 2. Global Rifampicin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rifampicin Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Intravenous Injection Product Picture
Figure 6. Global Rifampicin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Rifampicin Market Share by Application in 2022 & 2029
Figure 8. Tuberculosis
Figure 9. Leprosy
Figure 10. Legionnaire's Disease
Figure 11. Others
Figure 12. Rifampicin Report Years Considered
Figure 13. Global Rifampicin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Rifampicin Revenue 2018-2029 (US$ Million)
Figure 15. Global Rifampicin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Rifampicin Revenue Market Share by Region (2018-2029)
Figure 17. Global Rifampicin Sales 2018-2029 ((MT)
Figure 18. Global Rifampicin Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Rifampicin Sales YoY (2018-2029) & (MT)
Figure 20. US & Canada Rifampicin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Rifampicin Sales YoY (2018-2029) & (MT)
Figure 22. Europe Rifampicin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Rifampicin Sales YoY (2018-2029) & (MT)
Figure 24. China Rifampicin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Rifampicin Sales YoY (2018-2029) & (MT)
Figure 26. Asia (excluding China) Rifampicin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Rifampicin Sales YoY (2018-2029) & (MT)
Figure 28. Middle East, Africa and Latin America Rifampicin Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Rifampicin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Rifampicin in the World: Market Share by Rifampicin Revenue in 2022
Figure 31. Global Rifampicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Rifampicin Sales Market Share by Type (2018-2029)
Figure 33. Global Rifampicin Revenue Market Share by Type (2018-2029)
Figure 34. Global Rifampicin Sales Market Share by Application (2018-2029)
Figure 35. Global Rifampicin Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Rifampicin Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Rifampicin Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Rifampicin Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Rifampicin Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Rifampicin Revenue Share by Country (2018-2029)
Figure 41. US & Canada Rifampicin Sales Share by Country (2018-2029)
Figure 42. U.S. Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Rifampicin Sales Market Share by Type (2018-2029)
Figure 45. Europe Rifampicin Revenue Market Share by Type (2018-2029)
Figure 46. Europe Rifampicin Sales Market Share by Application (2018-2029)
Figure 47. Europe Rifampicin Revenue Market Share by Application (2018-2029)
Figure 48. Europe Rifampicin Revenue Share by Country (2018-2029)
Figure 49. Europe Rifampicin Sales Share by Country (2018-2029)
Figure 50. Germany Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 51. France Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 55. China Rifampicin Sales Market Share by Type (2018-2029)
Figure 56. China Rifampicin Revenue Market Share by Type (2018-2029)
Figure 57. China Rifampicin Sales Market Share by Application (2018-2029)
Figure 58. China Rifampicin Revenue Market Share by Application (2018-2029)
Figure 59. Asia Rifampicin Sales Market Share by Type (2018-2029)
Figure 60. Asia Rifampicin Revenue Market Share by Type (2018-2029)
Figure 61. Asia Rifampicin Sales Market Share by Application (2018-2029)
Figure 62. Asia Rifampicin Revenue Market Share by Application (2018-2029)
Figure 63. Asia Rifampicin Revenue Share by Region (2018-2029)
Figure 64. Asia Rifampicin Sales Share by Region (2018-2029)
Figure 65. Japan Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 69. India Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Rifampicin Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Rifampicin Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Rifampicin Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Rifampicin Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Rifampicin Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Rifampicin Sales Share by Country (2018-2029)
Figure 76. Brazil Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Rifampicin Revenue (2018-2029) & (US$ Million)
Figure 81. Rifampicin Value Chain
Figure 82. Rifampicin Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries